Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
Kubicek GJ, Werner-Wasik M, Machtay M, Mallon G, Myers T, Ramirez M, Andrews D, Curran WJ Jr, Dicker AP. Kubicek GJ, et al. Among authors: andrews d. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):433-9. doi: 10.1016/j.ijrobp.2008.08.050. Epub 2008 Dec 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19084346 Free PMC article. Clinical Trial.
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
Wuthrick EJ, Kamrava M, Curran WJ Jr, Werner-Wasik M, Camphausen KA, Hyslop T, Axelrod R, Andrews DW, Glass J, Machtay M, Dicker AP. Wuthrick EJ, et al. Cancer. 2011 Dec 15;117(24):5548-59. doi: 10.1002/cncr.26216. Epub 2011 Jun 3. Cancer. 2011. PMID: 21647871 Free PMC article. Clinical Trial.
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP. Den RB, et al. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):321-8. doi: 10.1016/j.ijrobp.2012.04.017. Epub 2012 Jun 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 22687197 Free PMC article. Clinical Trial.
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
Wuthrick EJ, Curran WJ Jr, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, Haacke EM, Hillman GG, Dicker AP. Wuthrick EJ, et al. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):369-75. doi: 10.1016/j.ijrobp.2014.05.034. Epub 2014 Aug 4. Int J Radiat Oncol Biol Phys. 2014. PMID: 25104067 Free PMC article.
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W. Williams NL, et al. Among authors: andrews dw. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816150 Clinical Trial.
Immediate side effects of stereotactic radiotherapy and radiosurgery.
Werner-Wasik M, Rudoler S, Preston PE, Hauck WW, Downes BM, Leeper D, Andrews D, Corn BW, Curran WJ Jr. Werner-Wasik M, et al. Among authors: andrews d. Int J Radiat Oncol Biol Phys. 1999 Jan 15;43(2):299-304. doi: 10.1016/s0360-3016(98)00410-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10030253
1,231 results